摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1-氨基丙基)苯胺 | 133332-54-4

中文名称
4-(1-氨基丙基)苯胺
中文别名
——
英文名称
4-(1-Aminopropyl)aniline
英文别名
——
4-(1-氨基丙基)苯胺化学式
CAS
133332-54-4
化学式
C9H14N2
mdl
——
分子量
150.22
InChiKey
IYWMAXHBPYOXNJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    284.4±15.0 °C(Predicted)
  • 密度:
    1.032±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    52
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • [EN] GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE L'HORMONE DE LIBÉRATION DES GONADOTROPHINES, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT
    申请人:SK CHEMICALS CO LTD
    公开号:WO2013129879A1
    公开(公告)日:2013-09-06
    The present invention provides gonadotropin releasing hormone receptor antagonists and the pharmaceutical composition comprising the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as Alzheimer disease.
    本发明提供了促性腺激素释放激素受体拮抗剂及包括其的药物组合物,可用于预防或治疗与性激素相关的疾病,如子宫内膜异位症、闭经、月经不调、子宫肌瘤、子宫肌瘤、多囊卵巢综合征、红斑狼疮、多毛症、性早熟、身材矮小、痤疮、脱发、性腺类固醇依赖性肿瘤、促性腺激素产生性垂体腺瘤、睡眠呼吸暂停、肠易激综合征、经前综合征、良性前列腺增生、避孕和不孕症,以及阿尔茨海默病。
  • GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    申请人:SK CHEMICALS CO., LTD.
    公开号:US20150166558A1
    公开(公告)日:2015-06-18
    Disclosed are a gonadotropin releasing hormone receptor antagonist and a pharmaceutical composition including the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as Alzheimer disease.
    揭示了一种促性腺激素释放激素受体拮抗剂和包括该拮抗剂的药物组合物,可用于预防或治疗与性激素相关的疾病,如子宫内膜异位症、闭经、月经不调、子宫肌瘤、子宫纤维瘤、多囊卵巢综合征、红斑狼疮、多毛症、性早熟、身材矮小、痤疮、脱发、性腺类固醇依赖性肿瘤、促性腺激素产生垂体腺瘤、睡眠呼吸暂停、肠易激综合征、经前综合征、良性前列腺增生、避孕和不孕症,以及阿尔茨海默病。
  • Alicyclic diamines, alicyclic diisocyanates and polyisocyanato-isocyanurates and method for the preparation thereof
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0394058A1
    公开(公告)日:1990-10-24
    Herein disclosed are an α-(aminocydonexyl)alkylamine represented by the following general formula (II): wherein R represents hydrogen atom or a lower alkyl group having 1 to 5 carbon atoms, provided that the amino group bonded to the cyclohexyl group may be in either of the 2-, 3- and 4-positions and a method for preparing it; an a-(isocyanatocyclohexyl)alkylisocyanate of Formula (II) wherein the amino groups are replaced with isocyanato groups and a method for preparing it; polyisocyanato-isocyanurate represented by the following general formula (IV): wherein Ri, R2 and R3 may be the same or different and each represents a group represented by the following general formula: wherein R represents hydrogen atom or an alkyl group having 1 to 5 carbon atoms and n is an integer ranging from 1 to 5 and a method for preparing it; and a resin obtained by polymerizing an organic polyisocyanate containing not lower than 10% by weight of the polyisocyanato-isocyanurate represented by Formula (IV) and a compound having at least two active hydrogen atoms as well as a resin composition for coating materials which comprises the resin.
    本发明公开了由以下通式(II)代表的α-(氨基环己基)烷基胺: 其中 R 代表氢原子或具有 1 至 5 个碳原子的低级烷基,但与环己基键合的氨基可位于 2、3 和 4 位中的任一位置;式(II)的 a-(异氰基环己基)烷基异氰酸酯(其中氨基被异氰酸基取代)及其制备方法;由以下通式(IV)表示的聚异氰酸酯: 其中 Ri、R2 和 R3 可以相同或不同,且各自代表下式通式所代表的基团: 其中 R 代表氢原子或具有 1 至 5 个碳原子的烷基,n 为 1 至 5 的整数,以及制备方法;通过聚合有机多异氰酸酯获得的树脂,该有机多异氰酸酯含有不低于 10%(按重量计)的由式(IV)代表的多异氰酸酯和至少具有两个活泼氢原子的化合物,以及包含该树脂的用于涂层材料的树脂组合物。
  • AUTOMOTIVE ADHESIVE
    申请人:KONISHI CO., LTD.
    公开号:EP1380625A1
    公开(公告)日:2004-01-14
    Provided is an automobile adhesive comprising (a) an alkoxysilyl group-containing polymer, (b) a hardening catalyst for the above-mentioned alkoxysilyl group-containing polymer, (c) a vinyl-based polymer, (d) an epoxy resin, (e) an epoxy hardening agent, and (f) an inorganic filler, wherein the adhesive immediately after mixing all of the above-mentioned (a) to (f) has a viscosity at 23°C of 100 to 700 Pa • s and a structural viscosity index of 2.0 to 4.0.
    本发明提供了一种汽车粘合剂,该粘合剂包括(a)含烷氧基硅烷基聚合物;(b)上述含烷氧基硅烷基聚合物的硬化催化剂;(c)乙烯基聚合物;(d)环氧树脂;(e)环氧固化剂;以及(f)无机填料。0 至 4.0。
  • REACTIVE HOT-MELT RESIN COMPOSITION AND REACTIVE HOT-MELT ADHESIVE
    申请人:KONISHI CO., LTD.
    公开号:EP1788035A1
    公开(公告)日:2007-05-23
    Provided is a fast-curing reactive hot-melt resin composition and an adhesive, using a resin having a silicon-containing functional group. The reactive hot-melt resin composition contains a curable resin having a hydrolytic silyl group in the molecule and at least one boron compound selected from the group consisting of boron halides and boron halide complexes. The reactive hot-melt adhesive is composed of the resin composition.
    本发明提供了一种使用具有含硅官能团的树脂的快速固化反应性热熔树脂组合物和粘合剂。 该反应性热熔胶树脂组合物含有分子中含有水解硅基的可固化树脂和至少一种从卤化硼和卤化硼络合物组成的组中选出的硼化合物。反应性热熔胶由该树脂组合物组成。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐